SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-023848
Filing Date
2019-11-18
Accepted
2019-11-18 12:30:59
Documents
79
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_americanbrivision.htm 10-Q 782255
2 CERTIFICATION f10q0919ex31-1_americanbri.htm EX-31.1 12176
3 CERTIFICATION f10q0919ex31-2_americanbri.htm EX-31.2 11853
4 CERTIFICATION f10q0919ex32-1_americanbri.htm EX-32.1 4852
5 CERTIFICATION f10q0919ex32-2_americanbri.htm EX-32.2 4359
  Complete submission text file 0001213900-19-023848.txt   5396905

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE abvcd-20190930.xml EX-101.INS 1003632
7 XBRL SCHEMA FILE abvcd-20190930.xsd EX-101.SCH 65771
8 XBRL CALCULATION FILE abvcd-20190930_cal.xml EX-101.CAL 70322
9 XBRL DEFINITION FILE abvcd-20190930_def.xml EX-101.DEF 212522
10 XBRL LABEL FILE abvcd-20190930_lab.xml EX-101.LAB 377550
11 XBRL PRESENTATION FILE abvcd-20190930_pre.xml EX-101.PRE 332487
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 191226694
SIC: 2834 Pharmaceutical Preparations